InvestorsHub Logo
icon url

kairos

08/18/06 10:22 AM

#1008 RE: palacian #1007

Palacian i have a question about the 'toxic financing'. I would have expected the OS to have risen in the recent 10Q, ie. dilution, but there was no change. I don't understand how the financing is holding the price down if not dilution. any info in this regard would be appreciated.

thanks
bullthunder
icon url

Mikelongstock

08/18/06 10:23 AM

#1009 RE: palacian #1007

Well maybe I'm right paladinski. Lower lows stopped last year. I've only been in this stock since then. Trend, though, looks to be UP to me.
It's a biotech. There is no reasoning for ANY data. It doesn't matter if they have bad financing. All that crap IS irrelevant. Potential IS everything. How many micro biotechs actually have a revenue?? and what is their stock price.
Speculative? absolutely. Feasable, more than likely!!